메뉴 건너뛰기




Volumn 21, Issue 5, 2007, Pages 943-948

Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: The importance of escalating the cell dose to maximize therapeutic efficacy

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BCR ABL PROTEIN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; PROTEIN TYROSINE KINASE INHIBITOR;

EID: 34247616077     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404641     Document Type: Article
Times cited : (42)

References (32)
  • 1
    • 0019861205 scopus 로고
    • Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation
    • Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304: 1529-1533.
    • (1981) N Engl J Med , vol.304 , pp. 1529-1533
    • Weiden, P.L.1    Sullivan, K.M.2    Flournoy, N.3    Storb, R.4    Thomas, E.D.5
  • 2
    • 0023690307 scopus 로고
    • Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion
    • Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.. Ann Intern Med 1988; 108: 806-814.
    • (1988) Ann Intern Med , vol.108 , pp. 806-814
    • Goldman, J.M.1    Gale, R.P.2    Horowitz, M.M.3    Biggs, J.C.4    Champlin, R.E.5    Gluckman, E.6
  • 3
    • 0025678601 scopus 로고
    • Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
    • Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
    • (1990) Blood , vol.76 , pp. 2462-2465
    • Kolb, H.J.1    Mittermuller, J.2    Clemm, C.3    Holler, E.4    Ledderose, G.5    Brehm, G.6
  • 5
    • 2942712161 scopus 로고    scopus 로고
    • Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
    • Collins Jr RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
    • (1997) J Clin Oncol , vol.15 , pp. 433-444
    • Collins Jr, R.H.1    Shpilberg, O.2    Drobyski, W.R.3    Porter, D.L.4    Giralt, S.5    Champlin, R.6
  • 6
    • 0034667532 scopus 로고    scopus 로고
    • Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    • Dazzi F, Szydlo RM, Cross NC, Craddock C, Kaeda J, Kanfer E et al. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 2000; 96: 2712-2716.
    • (2000) Blood , vol.96 , pp. 2712-2716
    • Dazzi, F.1    Szydlo, R.M.2    Cross, N.C.3    Craddock, C.4    Kaeda, J.5    Kanfer, E.6
  • 7
    • 0037100284 scopus 로고    scopus 로고
    • Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: Prognostic relevance of the initial cell dose
    • Guglielmi C, Arcese W, Dazzi F, Brand R, Bunjes D, Verdonck LF et al. Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: Prognostic relevance of the initial cell dose. Blood 2002; 100 397-405.
    • (2002) Blood , vol.100 , pp. 397-405
    • Guglielmi, C.1    Arcese, W.2    Dazzi, F.3    Brand, R.4    Bunjes, D.5    Verdonck, L.F.6
  • 8
    • 0033844816 scopus 로고    scopus 로고
    • Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome
    • Lokhorst HM, Schattenberg A, Cornelissen JJ, van Oers MH, Fibbe W, Russell I et al. Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome. J Clin Oncol 2000; 18: 3031-3037.
    • (2000) J Clin Oncol , vol.18 , pp. 3031-3037
    • Lokhorst, H.M.1    Schattenberg, A.2    Cornelissen, J.J.3    van Oers, M.H.4    Fibbe, W.5    Russell, I.6
  • 9
    • 0034651931 scopus 로고    scopus 로고
    • Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
    • Porter DL, Collins Jr RH, Hardy C, Keman NA, Drobyski WR, Giralt S et al. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000; 95: 1214-1221.
    • (2000) Blood , vol.95 , pp. 1214-1221
    • Porter, D.L.1    Collins Jr, R.H.2    Hardy, C.3    Keman, N.A.4    Drobyski, W.R.5    Giralt, S.6
  • 11
    • 0028237517 scopus 로고
    • Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse
    • van Rhee F, Lin F, Cullis JO, Spencer A, Cross NC, Chase A et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994; 83: 3377-3383.
    • (1994) Blood , vol.83 , pp. 3377-3383
    • van Rhee, F.1    Lin, F.2    Cullis, J.O.3    Spencer, A.4    Cross, N.C.5    Chase, A.6
  • 12
    • 0029100438 scopus 로고
    • Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
    • Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
    • (1995) Blood , vol.86 , pp. 2041-2050
    • Kolb, H.J.1    Schattenberg, A.2    Goldman, J.M.3    Hertenstein, B.4    Jacobsen, N.5    Arcese, W.6
  • 13
    • 0032982237 scopus 로고    scopus 로고
    • In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion
    • Schattenberg A, Schaap N, Van De Wiel-Van Kemenade E, Bar B, Preijers F, Van Der Maazen R et al. In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion. Leuk Lymphoma 1999; 32: 317-325.
    • (1999) Leuk Lymphoma , vol.32 , pp. 317-325
    • Schattenberg, A.1    Schaap, N.2    Van De Wiel-Van Kemenade, E.3    Bar, B.4    Preijers, F.5    Van Der Maazen, R.6
  • 15
    • 0029092530 scopus 로고
    • Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease
    • Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-1268.
    • (1995) Blood , vol.86 , pp. 1261-1268
    • Mackinnon, S.1    Papadopoulos, E.B.2    Carabasi, M.H.3    Reich, L.4    Collins, N.H.5    Boulad, F.6
  • 16
    • 0030831669 scopus 로고    scopus 로고
    • Bone marrow transplantation for chronic myeloid leukaemia: The effects of differing criteria for defining chronic phase on probabilities of survival and relapse
    • Savage DG, Szydlo RM, Chase A, Apperley JF, Goldman JM. Bone marrow transplantation for chronic myeloid leukaemia: The effects of differing criteria for defining chronic phase on probabilities of survival and relapse. Br J Haematol 1997; 99: 30-35.
    • (1997) Br J Haematol , vol.99 , pp. 30-35
    • Savage, D.G.1    Szydlo, R.M.2    Chase, A.3    Apperley, J.F.4    Goldman, J.M.5
  • 17
    • 0028863238 scopus 로고
    • Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: Major prognostic impact of HLA class I identity between donor and recipient
    • Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F et al. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: Major prognostic impact of HLA class I identity between donor and recipient. Blood 1995; 86: 3590-3597.
    • (1995) Blood , vol.86 , pp. 3590-3597
    • Spencer, A.1    Szydlo, R.M.2    Brookes, P.A.3    Kaminski, E.4    Rule, S.5    van Rhee, F.6
  • 18
    • 13344250478 scopus 로고    scopus 로고
    • Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction
    • Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F et al. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood 1996; 87: 1549-1555.
    • (1996) Blood , vol.87 , pp. 1549-1555
    • Hochhaus, A.1    Lin, F.2    Reiter, A.3    Skladny, H.4    Mason, P.J.5    van Rhee, F.6
  • 19
    • 0042744710 scopus 로고    scopus 로고
    • Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib
    • Lin F, Drummond M, O'Brien S, Cervantes F, Goldman J, Kaeda J. Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib. Blood 2003; 102: 1143.
    • (2003) Blood , vol.102 , pp. 1143
    • Lin, F.1    Drummond, M.2    O'Brien, S.3    Cervantes, F.4    Goldman, J.5    Kaeda, J.6
  • 20
    • 33646590620 scopus 로고    scopus 로고
    • Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: An attempt to define patients who may not require further therapy
    • Kaeda J, O'Shea D, Szydlo RM, Olavarria E, Dazzi F, Marin D et al. Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: An attempt to define patients who may not require further therapy. Blood 2006; 107:4171-4176.
    • (2006) Blood , vol.107 , pp. 4171-4176
    • Kaeda, J.1    O'Shea, D.2    Szydlo, R.M.3    Olavarria, E.4    Dazzi, F.5    Marin, D.6
  • 21
    • 0024694111 scopus 로고
    • Proposals for standardized reporting of results of bone marrow transplantation for leukaemia
    • Clift R, Goldman J, Gratwohl A, Horowitz M. Proposals for standardized reporting of results of bone marrow transplantation for leukaemia. Bone Marrow Transplant 1989; 4: 445-448.
    • (1989) Bone Marrow Transplant , vol.4 , pp. 445-448
    • Clift, R.1    Goldman, J.2    Gratwohl, A.3    Horowitz, M.4
  • 22
    • 0033962014 scopus 로고    scopus 로고
    • Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
    • Dazzi F, Szydlo RM, Craddock C, Cross NC, Kaeda J, Chase A et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 2000; 95: 67-71.
    • (2000) Blood , vol.95 , pp. 67-71
    • Dazzi, F.1    Szydlo, R.M.2    Craddock, C.3    Cross, N.C.4    Kaeda, J.5    Chase, A.6
  • 23
    • 0027275074 scopus 로고
    • Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation
    • Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929-1936.
    • (1993) Blood , vol.82 , pp. 1929-1936
    • Cross, N.C.1    Feng, L.2    Chase, A.3    Bungey, J.4    Hughes, T.P.5    Goldman, J.M.6
  • 24
    • 0016187133 scopus 로고
    • Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors
    • Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
    • (1974) Transplantation , vol.18 , pp. 295-304
    • Glucksberg, H.1    Storb, R.2    Fefer, A.3    Buckner, C.D.4    Neiman, P.E.5    Clift, R.A.6
  • 25
    • 0031470510 scopus 로고    scopus 로고
    • The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation
    • Raanani P, Dazzi F, Sohal J, Szydlo RM, van Rhee F, Reiter A et al. The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. Br J Haematol 1997; 99: 945-950.
    • (1997) Br J Haematol , vol.99 , pp. 945-950
    • Raanani, P.1    Dazzi, F.2    Sohal, J.3    Szydlo, R.M.4    van Rhee, F.5    Reiter, A.6
  • 26
    • 0032544083 scopus 로고    scopus 로고
    • +) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation
    • +) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc Natl Acad Sci USA 1998; 95: 10152-10157.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 10152-10157
    • Smit, W.M.1    Rijnbeek, M.2    van Bergen, C.A.3    Fibbe, W.E.4    Willemze, R.5    Falkenburg, J.H.6
  • 27
    • 30944446623 scopus 로고    scopus 로고
    • Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation
    • Russell NH, Byrne JL, Faulkner RD, Gilyead M, Das-Gupta EP, Haynes AP. Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant 2005; 36: 437-441.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 437-441
    • Russell, N.H.1    Byrne, J.L.2    Faulkner, R.D.3    Gilyead, M.4    Das-Gupta, E.P.5    Haynes, A.P.6
  • 28
    • 0027465548 scopus 로고
    • Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation
    • Schwarer AP, Jiang YZ, Brookes PA, Barrett AJ, Batchelor JR, Goldman JM et al. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. Lancet 1993; 341: 203-205.
    • (1993) Lancet , vol.341 , pp. 203-205
    • Schwarer, A.P.1    Jiang, Y.Z.2    Brookes, P.A.3    Barrett, A.J.4    Batchelor, J.R.5    Goldman, J.M.6
  • 29
    • 0037418284 scopus 로고    scopus 로고
    • Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
    • Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742-2747.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 2742-2747
    • Marijt, W.A.1    Heemskerk, M.H.2    Kloosterboer, F.M.3    Goulmy, E.4    Kester, M.G.5    van der Hoorn, M.A.6
  • 30
    • 0141613838 scopus 로고    scopus 로고
    • Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    • Olavarria E, Ottmann OG, Deininger M, Clark RE, Bandini G, Byrne J et al. Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia 2003; 17: 1707-1712.
    • (2003) Leukemia , vol.17 , pp. 1707-1712
    • Olavarria, E.1    Ottmann, O.G.2    Deininger, M.3    Clark, R.E.4    Bandini, G.5    Byrne, J.6
  • 31
    • 33744503915 scopus 로고    scopus 로고
    • A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation
    • Weisser M, Tischer J, Schnittger S, Schoch C, Ledderose G, Kolb HJ. A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation. Haematologica 2006; 91 663-666.
    • (2006) Haematologica , vol.91 , pp. 663-666
    • Weisser, M.1    Tischer, J.2    Schnittger, S.3    Schoch, C.4    Ledderose, G.5    Kolb, H.J.6
  • 32
    • 28544440836 scopus 로고    scopus 로고
    • Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation
    • Savani BN, Montero A, Kurlander R, Childs R, Hensel N, Barrett AJ. Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 36: 1009-1015.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 1009-1015
    • Savani, B.N.1    Montero, A.2    Kurlander, R.3    Childs, R.4    Hensel, N.5    Barrett, A.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.